UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000014209
Receipt number R000016550
Scientific Title Biomarker study using cell free DNA in patients with gastric cancer
Date of disclosure of the study information 2014/06/09
Last modified on 2014/06/09 16:47:38

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Biomarker study using cell free DNA in patients with gastric cancer

Acronym

Cell-free DNA in CG

Scientific Title

Biomarker study using cell free DNA in patients with gastric cancer

Scientific Title:Acronym

Cell-free DNA in CG

Region

Japan


Condition

Condition

advanced gastric cancer

Classification by specialty

Gastroenterology Hematology and clinical oncology

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

To evaluate somatic mutations and expression levels of cytokines as a predictive biomarker for anti-cancer therapy in plasma and tumor tissues from patients with advanced gastric cancer

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

To assess the association between the presence of some somatic mutations and expression levels of cytokines in plasma and efficacy of some anti-tumor drugs.

Key secondary outcomes



Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

those who gave an informed consent about this study.

Key exclusion criteria

none

Target sample size



Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Kazuhiko Nakagawa

Organization

Kindai University Faculty of Medicine

Division name

Medical Oncology Department

Zip code


Address

377-2 Ohnohigashi, Osakasayama

TEL

072-366-0221

Email

nakagawa@med.kindai.ac.jp


Public contact

Name of contact person

1st name
Middle name
Last name Junji Tsurutani

Organization

Kindai University Faculty of Medicine

Division name

Medical Oncology Department

Zip code


Address

377-2 Ohnohigashi, Osakasayama

TEL

072-366-0221

Homepage URL


Email

tsurutani_j@dotd.med.kindai.ac.jp


Sponsor or person

Institute

Kindai University Faculty of Medicine

Institute

Department

Personal name



Funding Source

Organization

Ministry of Education, Culture, Sports, Science and Technology

Organization

Division

Category of Funding Organization

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2014 Year 06 Month 09 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Open public recruiting

Date of protocol fixation

2014 Year 06 Month 01 Day

Date of IRB


Anticipated trial start date

2014 Year 06 Month 01 Day

Last follow-up date


Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

Statistical consideration is applied to this study.


Management information

Registered date

2014 Year 06 Month 09 Day

Last modified on

2014 Year 06 Month 09 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000016550


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name